10-Q Filing

IOVANCE BIOTHERAPEUTICS, INC. CIK: 1425205 Q1 2015

Filing Information

Form Type	10-Q
Accession Number	`0001144204-15-029130`
Period End Date	20150331
Filing Date	20150511
Fiscal Year	2015
Fiscal Period	Q1
XBRL Instance	lbio-20150331.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 56 Income Statement 16 Cash Flow Statement 37 Stockholders Equity 11

Balance Sheet 56 line items

Line Item	Tag	Value	Unit	Period
Property and equipment, accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$104.22K	USD	Point-in-time
Property and equipment, accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$289.67K	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$17.94M	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	50.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$44.91M	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	50.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$111.28M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$19.67M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	5,694.00	shares	Point-in-time
Prepaid expenses and deposits	`PrepaidExpenseAndOtherAssetsCurrent`	$128.88K	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	3,694.00	shares	Point-in-time
Prepaid expenses and deposits	`PrepaidExpenseAndOtherAssetsCurrent`	$66.13K	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	3,694.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	5,694.00	shares	Point-in-time
Total Current Assets	`AssetsCurrent`	$111.41M	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$44.98M	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	-	USD	Point-in-time
Property and equipment, net of accumulated depreciation of $289,672 and $104,223	`PropertyPlantAndEquipmentNet`	$2.13M	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	-	USD	Point-in-time
Property and equipment, net of accumulated depreciation of $289,672 and $104,223	`PropertyPlantAndEquipmentNet`	$1.53M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	150.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	150.00M	shares	Point-in-time
Total Assets	`Assets`	$46.51M	USD	Point-in-time
Total Assets	`Assets`	$113.54M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	33.75M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	44.87M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	44.87M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	33.75M	shares	Point-in-time
Common stock to be issued shares	`CommonStockToBeIssuedShares`	303,125.00	shares	Point-in-time
Common stock to be issued shares	`CommonStockToBeIssuedShares`	303,125.00	shares	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.25M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.11M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$717.85K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$327.85K	USD	Point-in-time
Accrued payable to officers and former directors	`AccountsPayableRelatedPartiesCurrent`	$85.50K	USD	Point-in-time
Accrued payable to officers and former directors	`AccountsPayableRelatedPartiesCurrent`	$85.50K	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$1.66M	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$1.91M	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, $0.001 par value; 50,000,000 shares authorized, 3,694 shares and 5,694 shares issued and outstanding, respectively	`PreferredStockValue`	$4.00	USD	Point-in-time
Preferred stock, $0.001 par value; 50,000,000 shares authorized, 3,694 shares and 5,694 shares issued and outstanding, respectively	`PreferredStockValue`	$6.00	USD	Point-in-time
Common stock, $0.000041666 par value; 150,000,000 shares authorized, 44,871,888 and 33,750,188 shares issued and outstanding, respectively	`CommonStockValue`	$1.41K	USD	Point-in-time
Common stock, $0.000041666 par value; 150,000,000 shares authorized, 44,871,888 and 33,750,188 shares issued and outstanding, respectively	`CommonStockValue`	$1.87K	USD	Point-in-time
Common stock to be issued, 303,125 shares	`CommonStockToBeIssuedValue`	$245.15K	USD	Point-in-time
Common stock to be issued, 303,125 shares	`CommonStockToBeIssuedValue`	$245.15K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$193.24M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$121.16M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-76.56M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-81.86M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$111.63M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$44.85M	USD	Point-in-time
Total Liabilities and Stockholders' Equity	`LiabilitiesAndStockholdersEquity`	$113.54M	USD	Point-in-time
Total Liabilities and Stockholders' Equity	`LiabilitiesAndStockholdersEquity`	$46.51M	USD	Point-in-time

Income Statement 16 line items

Line Item	Tag	Value	Unit	Period
Revenues	`Revenues`	-	USD	1 Quarter
Share-based Compensation	`ShareBasedCompensation`	$919.35K	USD	1 Quarter
Revenues	`Revenues`	-	USD	1 Quarter
Share-based Compensation	`ShareBasedCompensation`	$1.47M	USD	1 Quarter
Operating expenses (including $0 and $1,070,707 of non-cash share-based compensation costs)	`OperatingCostsAndExpenses`	$1.96M	USD	1 Quarter
Operating expenses (including $0 and $1,070,707 of non-cash share-based compensation costs)	`OperatingCostsAndExpenses`	$3.29M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$2.01M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$302.66K	USD	1 Quarter
Total costs and expenses	`OperatingExpenses`	$5.30M	USD	1 Quarter
Total costs and expenses	`OperatingExpenses`	$2.26M	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-2.26M	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-5.30M	USD	1 Quarter
Net Loss Per Share, Basic and Diluted	`EarningsPerShareBasicAndDiluted`	$-0.11	USD	1 Quarter
Net Loss Per Share, Basic and Diluted	`EarningsPerShareBasicAndDiluted`	$-0.14	USD	1 Quarter
Weighted-Average Common Shares Outstanding, Basic and Diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	20.80M	shares	1 Quarter
Weighted-Average Common Shares Outstanding, Basic and Diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	37.68M	shares	1 Quarter

Cash Flow Statement 37 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-2.26M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-5.30M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$185.45K	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$16.57K	USD	1 Quarter
Fair value of vested stock options	`StockOptionPlanExpense`	$901.65K	USD	1 Quarter
Fair value of vested stock options	`StockOptionPlanExpense`	$1.02M	USD	1 Quarter
Vesting of restricted shares issued for services	`FairValueOfVestedWarrantsGrantedForServices`	$450.44K	USD	1 Quarter
Vesting of restricted shares issued for services	`FairValueOfVestedWarrantsGrantedForServices`	$17.70K	USD	1 Quarter
Prepaid expenses and deposits	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$62.75K	USD	1 Quarter
Prepaid expenses and deposits	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-49.62K	USD	1 Quarter
Accounts payable and accrued expenses	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$-993.39K	USD	1 Quarter
Accounts payable and accrued expenses	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$248.96K	USD	1 Quarter
Net Cash Used In Operating Activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-3.46M	USD	1 Quarter
Net Cash Used In Operating Activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-2.27M	USD	1 Quarter
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$3.44K	USD	1 Quarter
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$782.14K	USD	1 Quarter
Proceeds from issuance of common stock upon conversion of warrants	`ProceedsFromIssuanceOfCommonStockUponConversionOfWarrants`	$2.30M	USD	1 Quarter
Proceeds from issuance of common stock upon conversion of warrants	`ProceedsFromIssuanceOfCommonStockUponConversionOfWarrants`	$542.50K	USD	1 Quarter
Proceeds from the issuance of common stock, net	`ProceedsFromIssuanceOfCommonStock`	$32.20M	USD	Point-in-time
Proceeds from the issuance of common stock, net	`ProceedsFromIssuanceOfCommonStock`	$68.31M	USD	1 Quarter
Proceeds from the issuance of common stock, net	`ProceedsFromIssuanceOfCommonStock`	$68.30M	USD	Annual
Net Cash Provided By Financing Activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$542.50K	USD	1 Quarter
Net Cash Provided By Financing Activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$70.61M	USD	1 Quarter
Net Increase (Decrease) In Cash And Cash Equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-1.73M	USD	1 Quarter
Net Increase (Decrease) In Cash And Cash Equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$66.37M	USD	1 Quarter
Cash and Cash Equivalents, Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$17.94M	USD	Point-in-time
Cash and Cash Equivalents, Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$44.91M	USD	Point-in-time
Cash and Cash Equivalents, Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$111.28M	USD	Point-in-time
Cash and Cash Equivalents, Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$19.67M	USD	Point-in-time
Cash and Cash Equivalents, End of Period	`CashAndCashEquivalentsAtCarryingValue`	$17.94M	USD	Point-in-time
Cash and Cash Equivalents, End of Period	`CashAndCashEquivalentsAtCarryingValue`	$44.91M	USD	Point-in-time
Cash and Cash Equivalents, End of Period	`CashAndCashEquivalentsAtCarryingValue`	$111.28M	USD	Point-in-time
Cash and Cash Equivalents, End of Period	`CashAndCashEquivalentsAtCarryingValue`	$19.67M	USD	Point-in-time
Interest	`InterestPaid`	-	USD	1 Quarter
Interest	`InterestPaid`	-	USD	1 Quarter
Income Taxes	`IncomeTaxesPaid`	-	USD	1 Quarter
Income Taxes	`IncomeTaxesPaid`	-	USD	1 Quarter

Stockholders Equity 11 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquity`	$111.63M	USD	Point-in-time
Balance	`StockholdersEquity`	$44.85M	USD	Point-in-time
Fair value of vested stock options	`AdjustmentsToAdditionalPaidInCapitalMarkToMarket`	$1.02M	USD	1 Quarter
Common stock issued upon exercise of warrants	`CommonStockIssuedUponExerciseOfWarrantsAmount`	$2.30M	USD	1 Quarter
Common stock issued upon conversion of preferred shares	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	-	USD	1 Quarter
Common stock sold in private placement, net of offering costs	`StockIssuedDuringPeriodValueOther`	$68.31M	USD	1 Quarter
Vesting of restricted shares issued for services	`AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition`	$450.44K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-2.26M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-5.30M	USD	1 Quarter
Balance	`StockholdersEquity`	$111.63M	USD	Point-in-time
Balance	`StockholdersEquity`	$44.85M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.